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Relative expression normalized to Actb 6.4% Figure S1 , related to Figure 1 . Effect of Prmt1 knockdown and AMI-408 treatment on leukemogenesis A. Prmt1 knockdown using shPrmt1-2 specifically suppresses MLL-EEN, MLL-GAS7 and MOZ-TIF2 colony formation in replating assay. Shown are mean and SD (n=3). B. RT-qPCR validation of Prmt1 knockdown by shPrmt1-2 in leukemic cells as indicated. Shown are mean and SD (n=3). C. Prmt1 knockdown in MLL-GAS7 and MOZ-TIF2 leukemia cells induces the up-regulation of myeloid surface marker Mac1 expression as revealed by FACS analysis. D. Cell cycle analysis revealed an increased in G1 and decreased S phase population in both MLL-GAS7 and MOZ-TIF2 leukemia cells after Prmt1 knockdown. Shown are mean and SD (n=3). E. Prmt1 knockdown in MLL-GAS7 and MOZ-TIF2 leukemia cells with two independent Prmt1 shRNA results in increased apoptotic cell death as revealed by Annexin V-PI staining. Shown are mean and SD (n=3 Figure 6H , which is consistent with the inhibition of KDM4C demethylation activity. E. Representative FACS plot of bone marrow engraftment of human primary leukemia MLL3 in NSG mice from control and SD70 treated groups. They were analysed by FACS with human CD33 and CD45 staining. Engraftment of MLL3 leukemia cells was indicated by CD45+CD33+ population. F. A summary of the percentage of MLL3 human primary leukemia engraftment in the bone marrow, spleen and liver in both the control and SD70 treatment cohort (n=5). SD70 treatment significantly inhibited the engraftment of human leukemia cells in the organs analysed (unpaired t-test; ***p<0.001). G. 
Supplemental Experimental Procedures

Plasmid constructs
Leukemia fusions and their deletion mutant constructs were cloned into MSCV retroviral vectors (Clontech) or pcDNA3-FLAG expression vector to generate FLAG-tagged expression plasmids. To generate myc-tagged expression constructs, genes of interest were subcloned into pCS2+MT vector. Most of the histone demethylase family genes were derived from IMAGE clones and subsequently subcloned into pRRL-3xFLAG lentiviral vector. Kdm4 demethylase family plasmids were kindly provided by Kristian Helin & Thomas Jenuwein; KDM3A/B were gifts of Zhang Yi. MSCV-MOZ-TIF2 is a kind gift from Brian Huntly. All plasmid constructs were confirmed by DNA sequencing. Prmt1 shRNA constructs were prepared as described (Cheung et al., 2007) . Kdm4c shRNAs in pLKO lentiviral vector were kind gifts from Bill Hahn (shKdm4c TRCN0000103550, shKdm4c#2 TRCN0000103553 from Sigma Aldrich). Lentiviral vector harbouring luciferase reporter and hygromycin resistance gene (pCDH-CMV-luc-EF1-Hygro) was kindly provided by Lou Chesler.
Cell lines
Murine leukemia cell lines (E2A-PBX, MN1, MOZ-TIF2, MLL-AF9, MLL-ENL and MLL-GAS7) were established from retroviral transduction transformation assay (RTTA) as described (Zeisig and So, 2009 ) and cultured in RPMI with 20% FCS, 20% WEHI conditioned medium, 100 unit/ml penicillin and 100 g/ml streptomycin (Sigma). Human leukemia cell lines NB4 was kindly provided by Arthur Zelent, THP1 by Mel Greaves, KASUMI by Olaf Heidenreich and K562, KG1, SEM, and HB11;19 were collected from ATCC. They were cultured in RPMI supplemented with 10% FCS, 100 unit/ml penicillin and 100 g/ml streptomycin. Primary human patient samples (MLL1-3 and non-MLL1-3) were cultured in IMEM supplement with 10% FBS, 1X Glutamax (Invitrogen), 10ng/ml interleukin 3 (IL3), 10ng/ml interleukin 6 (IL6), 10ng/ml stem cell factor (SCF), 10ng/ml thrombopoietin (TPO), 10ng/ml FLT3 ligand (all human; Peprotech), 100 unit/ml penicillin and 100 g/ml streptomycin.
Viral transduction and methylcellulose replating assay
RTTA was performed as previously described (Zeisig and So, 2009 ). Briefly, retroviral or lentiviral supernatants were collected 3 days after transfection of HEK293-GP cells (Clontech) or HEK293T respectively and used to transduce hematopoietic progenitors and stem cells positively selected for cKit expression by magnetic activated cell sorting (MACS; Miltenyi Biotec) from the bone marrow of 4-10 week old C57BL/6 mice or UbC-Luciferase transgenic mice kindly provided by Andrew Kung (Becker et al., 2006) . After spinoculation by centrifugation at 500  g for 2 hours at 32 o C, transduced cells were cultured overnight in RPMI supplemented with 10% FCS, 20 ng/ml SCF, 10 ng/ml each of IL-3 and IL-6 (all murine; Peprotech). They were then plated in 1% methylcellulose (Stem Cell Technologies, Vancouver, BC, Canada) supplemented with the same cytokines plus 10 ng/ml GM-CSF (Peprotech) and 1 mg/ml geneticine or 30 g/ml blasticidine (Life Technology) for positive selection of transduced cells. For co-transduction experiments of leukemia fusions with shRNA constructs, the cells were co-selected with 2 g/ml puromycin and 1mg/mL geneticine. For Kdm4c knockdown rescue experiments, leukemia cells were cotransduced with Kdm4c shRNA and shRNA-resistant human KDM4C lentiviruses, and co-selected with 2 g/ml puromycin and 30 g/ml blasticidin. After 5-7 days culture colonies were counted to calculate the transduction efficiency. Single-cell suspensions (10 4 cells) of antibiotic resistant colonies were then replated in methylcellulose media supplemented with the same cytokines aforementioned without antibiotics. Subsequent replatings were usually repeated every 5-7 days.
In vivo Leukemogenesis assays
To generate full-blown murine leukemia cells ("leukemia cells" throughout the manuscript), 10 6 immortalized cells after the third round replating were injected via the tail vein into 6-10 weeks old syngeneic C57BL/6 mice which had received a sub-lethal dose of 5.25 Gy total body  irradiation ( 137 Cs). To study the effect of down-regulation of Prmt1 and Kdm4c on leukemogenesis in vivo, the mice were injected with 10 5 murine full-blown leukemia cells as indicated. In vivo experiments with Prmt1 knockdown were transduced with either control vector or shPrmt1 retrovirus and sorted by eEGFP signal for transduced cells. Transduced Kdm4c knockdown cells (also control vector transduced) were antibiotic selected prior to transplantation. Prmt1 knockout achieved by tamoxifen treatment were confirmed by PCR genotyping prior to transplantation. Mice were maintained and monitored for development of leukemia by FACS analysis. Tissues were fixed in buffered formalin, sectioned and stained with hematoxylin and eosin for histological analysis. For primary human sample MLL3, cells were transduced with control plasmid or shKDM4c plasmid. Transduced cells were antibiotic selected for 3 days and 10 5 selected cells were transplanted by intra-femoral injection into sublethally irradiated immunodeficient NOD/SCID/IL2Rg-/-(NSG) mice. For in vivo experiments involved bioluminescence imaging and quantification of the leukemia burden, murine leukemias were transformed in c-Kit positive bone marrow cells from Ubc-luciferase reportor C56BL6 mice (Becker et al., 2006) . Human leukemia was transduced with a lenitiviral luciferase reporter as indicated in the plasmid constructs section. Transplanted mice were injected with 150 mg/kg D-luciferin substrate intraperitoneally and bioluminescence image acquired using IVIS Lumina II® (Caliper; Perkin Elmer) with software Living Image® Verion 4.3.1. Briefly, D-luciferin was injected into the animals intraperitoneally 10 min before the imaging procedure. Animals were maintained in general anaesthesia by isoflurane and put into the IVIS chamber for photography and detection of photon emission (large binning, F=1.2, exposure time: 3 min). The leukemia burden were measured and quantified by the same software as instructed. All the animal works were performed according to the guidelines and regulations of Animal (Scientific Procedures) Act 1986.
GST-pulldown affinity assay
5 g of GST fusion protein was incubated with 1 mg HeLa cell lysate in NP-40 lysis buffer (150 mM NaCl, 50 mM Tris (pH 8), 5 mM EDTA, Complete Protease Inhibitor (Roche), 1% NP-40) for 2 hr at 4C, washed with lysis buffer, eluted with SDS sample buffer & finally resolved in 10% SDS-PAGE. Protein interaction was detected by Western blotting followed by ECL chemiluminescence kit (GE Healthcare Life Science) and developed on X-ray film.
Transfection & Immunoprecipitation
Subconfluent HEK293 cells were transfected using calcium precipitation and harvested after 36-48 hrs. For generic immunoprecipitation, transfected cells were lysed in NP-40 lysis buffer (150 mM NaCl, 50 mM Tris (pH 8), 5 mM EDTA, Complete Protease Inhibitor (Roche), 0.1% -0.5% NP-40) for 30 min at 4C, the lysates were cleared by centrifugation at 4C. Cell lysates were incubated with the respective antibody overnight and then precipitated with protein-A/G Dynabeads (Life Technologies) at 4C for 4 hr. For immunoprecipitation of FLAG-tagged protein, ANTI-FLAG M2 affinity agarose gel was used (Sigma Aldrich). Eluted proteins were resolved by SDS-PAGE and proteins of interest were detected with the corresponding antibody followed by Western blotting. Antibodies used for Western blotting are shown in Table 1 . Densitometry analysis on immunoblot was performed with ImageJ software (Ver 1.49) according to their instructions.
Quantitative real time RT-PCR
Total RNAs extraction was performed using RNeasy kit (Qiagen) and treated with DNase (Ambion) or Nucleospin RNA extraction kit (Macherey-Nagel). cDNA was prepared using SuperscriptIII reverse transcriptase with random hexamer (Life Technology). Quantitative real time PCR was prepared with either FAST SYBR-green or Taqman probe based chemistry (Applied Biosystems) with StepOnePlus Real-Time PCR system (Applied Biosystems). RT-qPCR experiments were run in triplicate using duplicated experimental samples and analysed by ∆∆CT method. Primer sequences are shown in Table  2 .
Generation of conditional Prmt1 knockout mice
Conditional Prmt1 knockout mouse models have been generated using targeted ES cell clones of C57BL/6 background provided by European Conditional Mouse Mutagenesis program (EUCOMM). Microinjections of the ES clones and the PCR confirmation of germline transmission were carried out by the Mammalian Genetics Unit in the Medical Research Council. The Prmt1 allele is specifically targeted with two loxP sites flanking exon 5 and 6, which encode part of the methyltransferase domain. Homozygous Prmt1 flox/flox mice were mated with heterozygous Rosa26-Cre-ER mice (Jackson Lab) to generate the conditional Prmt1 flox/flox Cre-ER/+ mice. All genotypes were confirmed by PCR. Deletion of Prmt1 in the established leukemia cell lines was induced by tamoxifen at a concentration of 50ng/ml (Sigma) after 72-96 hours.
Chromatin Immunoprecipitation
Chromatin immunoprecipitation were performed as described (Cheung et al., 2007) . Briefly, cells were fixed with 1% formaldedyde for 10-20 min at room temperature and then quenched with 0.125 M glycine for 5 min. To generate DNA fragments of 0.2-1 kb, 1-10x10 6 cells were sonicated by Bioruptor Nano (Diagenode) on maximum power for 10 min with 30s on-off interval. Chromatin fragments were incubated with the antibody overnight and collected in protein-A/G dynabeads (Life Technologies). Cross-linked products were reversed by heating overnight at 65C, incubated with RNase for 1 hr at 37C and then treated with proteinase K at 45C for 1 hr. Eluted DNA was purified using QIAquick PCR purification kit (Qiagen) and used for quantitative PCRs with SYBR green or Taqman according to the manufacturer's protocol. For the inducible MLL-GAS7-ER and MOZ-TIF2-ER coimmunoprecipitation experiment, 50 ng/ml tamoxifen was added to the culture medium for activation of the leukemia fusions. Antibodies used for ChIP experiment are shown in Table 1 . Primer sequences are shown in Table 3 .
Flow cytometry analysis and sorting
Flow cytometry analysis of murine leukemia were performed as described (Yeung and So, 2009 ) using c-Kit (2B8), Gr-1 (RB6-8C5), Mac-1 (M1/70), CD4 (GK1.5), CD8(53-6.7), B220 (RA3-6B2), CD45.1 (A20) and CD45.2 (104) antibodies (BioLegend) and analysed by BD LSRII (Cheung et al 2007) . FACS staining of human leukemia cells were performed using CD11B (ICRF44), CD14 (HCD14), CD33 (WM53), CD34 (581), CD38 (HB-7) and CD45 (H130) antibodies (BioLegend). To investigate the leukemic mice after transplantation, cells in bone marrow, spleen and liver were analysed. The donor cells were detected by CD45.1 + CD45.2 -population for murine leukemia, or CD45+CD33+ population for human leukemia. GFP-positive cells were sorted using BD FACSAria cell sorter. AnnexinV staining is performed according to manufacturer protocol (eBioscience). For cell cycle analysis, cells were fixed in cold 70% ethanol overnight, washed with PBS and treated with 100ug/ml RNAse plus propidium iodide at 37 o C for 30 min. The cell cycle profiles were analysed using FlowJo software (Ver 7.6.5).
Analysis of normal hematopoiesis in vitro and vivo
c-Kit enriched HSPC were isolated from the bone marrow of SJL mice (CD45.1) and transduced with control or shKdm4c lentivirus. After 48 hours puromycin selection, 1000 transduced cells were plated into methylcellulose containing GM-CSF, SCF, IL3 and IL6 for colony forming assays and CFU assays with additional 10ng/ml erythropoietin added. The number and types of colonies were counted after 1 week. To study the effect of Kdm4c knockdown on normal hematopoiesis in vivo, 2x10 5 transduced SJL donor cells (CD45.1) were transplanted together with 2x10 5 recipient bone marrow mononuclear cells into lethally irradiated C57BL/6 mice (CD45.2) by tail vein injection. Peripheral blood was collected after 6 weeks by tail vein bleeding and processed for the analysis of both myeloid and lymphoid population by FACS as described in the previous section (Yeung and So, 2009 ).
Nitro blue tetrazolium (NBT) reduction assay
NBT reduction assay was performed to determine myeloid differentiation. NBT was added to the liquid culture at a final concentration of 0.1% and incubated at 37 o C CO 2 incubator for 3hrs. The differentiated cells were indicated by the deposition of dark blue insoluble formazan (NBT positive cells) and the percentage of differentiated cells were counted under microscopy. At least 200 cells were counted in most of the cases.
RNA sequencing and GSEA analysis
For RNA sequencing and GSEA analysis, MOZ-TIF2, MLL-GAS7 and MLL-AF9 leukemic cells were derived from c-Kit positive bone marrow cells from wild type (MLL-AF9) or the conditional Prmt1 flox/flox CreER (MOZ-TIF2 and MLL-GAS7) animals by RTTA. Leukemic cells were obtained from the bone marrow of recipient animals after primary transplantation. Suppression of Kdm4c in MOZ-TIF2, MLL-GAS7 and MLL-AF9 leukemic cells were achieved by shRNA knockdown. Inactivation of Prmt1 was achieved by tamoxifen treatment for 3-4 days in vitro (MOZ-TIF2 and MLL-GAS7) and compared with corresponding leukemia cells treated by vehicle control.Total RNA was isolated using mirVana miRNA extraction kit (Ambion) or Nucleopsin RNA extraction kit (Macherey-Nagel). The RNA quality was determined by Bioanalyser 2100 (Agilent) prior to library preparation. RNA library was prepared using Truseq Stranded RNA LT kit (Illumina) and next generation sequencing was performed with HiSeq 2000/2500 (Illumina). The quality control analysis was performed on all the RNA-Seq fastq files using FastQC software (Babraham Bioinformatics). The reads were aligned using TopHat2 (Kim et al., 2013) and counted with HTSeq (Anders et al., 2015) . Further statistical comparisons were performed using DESeq or DESeq2 packages (Love et al., 2014) . Comparative supervised heatmaps were generated using DESeq2 package. The desktop client of gene set enrichment analysis (GSEA) (Subramanian et al., 2005) was downloaded from Broad Institute website. The weighted GSEA analysis was performed on pre-ranked gene list with the reference c2.all.v4.0.symbols.gmt [Curated] gene list and 10000 permutations. The list of pathways was reported at FDR<0.05, complied and analysed by VennPlex (Cai et al., 2013) to generate Venn diagram comparing differential alteration in signalling pathways. 
